Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

This study has been completed.
Sponsor:
Collaborator:
Bill and Melinda Gates Foundation
Information provided by:
Immtech Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT00802594
First received: December 3, 2008
Last updated: December 4, 2008
Last verified: December 2008